Marizyme appoints two new board members

Marizyme appoints two new board members

FORT COLLINS -- Marizyme, Inc., a publicly traded (OTC:MRZM) company focusing on acquiring late-stage drug assets for use in the acute care space for development and commercialization, today... Read More

Monday December 17, 2018 0 comments Tags: Fort Collins, Marizyme, James Sapirstein, Terry Brostowin, Michael Handley

CHD Bioscience partners with Dr. Reddy’s Labs for global licensing of DFA-02

CHD Bioscience partners with Dr. Reddy’s Labs for global licensing of DFA-02

FORT COLLINS -- India-based Dr. Reddys Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) and Fort Collins-based CHD Bioscience Inc. , a privately-held biopharmaceutical company, today... Read More

Thursday July 27, 2017 0 comments Tags: Fort Collins, CHD Bioscience, Dr. Reddy's Laboratories, Michael Handley, DFA-02

CHD Bioscience: Tests show Veriox effective against healthcare associated infections

CHD Bioscience: Tests show Veriox effective against healthcare associated infections

FORT COLLINS -- CHD Bioscience announced that preliminary independent testing conducted by ATS Labs in Minnesota has demonstrated the company's lead product -- Veriox -- to be effective against... Read More

By: InnovatioNews Thursday October 10, 2013 0 comments Tags: CHD Bioscience, CRE bacteria, Fort Collins, Michael Handley, VERIOX